No headlines found.
Accuray Expands Global Training Center Network With Opening of New Facility in Genolier, Switzerland
PRNewswire (Thu, 18-Apr 7:35 AM ET)
Accuray to Report Third Quarter Fiscal 2024 Financial Results on May 1, 2024
PRNewswire (Wed, 17-Apr 4:05 PM ET)
PRNewswire (Tue, 26-Mar 7:35 AM ET)
Accuray Incorporated to Speak at 36th Annual Roth Conference
PRNewswire (Mon, 4-Mar 4:30 PM ET)
Accuray Incorporated to Speak at Oppenheimer 34th Annual Healthcare MedTech & Services Conference
PRNewswire (Tue, 27-Feb 5:30 PM ET)
Quebec Cancer Center is First in Canada to Treat Cancer Patients Using the Accuray Radixact System
PRNewswire (Tue, 13-Feb 7:35 AM ET)
PRNewswire (Mon, 5-Feb 5:30 PM ET)
Accuray Reports Fiscal 2024 Second Quarter Financial Results
PRNewswire (Wed, 31-Jan 4:06 PM ET)
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.
Accuray trades on the NASDAQ stock market under the symbol ARAY.
As of April 23, 2024, ARAY stock price climbed to $2.22 with 410,507 million shares trading.
ARAY has a beta of 1.43, meaning it tends to be more sensitive to market movements. ARAY has a correlation of 0.11 to the broad based SPY ETF.
ARAY has a market cap of $220.15 million. This is considered a Small Cap stock.
Last quarter Accuray reported $107 million in Revenue and -$.10 earnings per share. This beat revenue expectation by $568,000 and missed earnings estimates by -$.05.
In the last 3 years, ARAY stock traded as high as $5.93 and as low as $1.70.
The top ETF exchange traded funds that ARAY belongs to (by Net Assets): VTI, IWM, VXF, IWO, VTWO.
ARAY has underperformed the market in the last year with a price return of -24.0% while the SPY ETF gained +24.3%. ARAY has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -24.5% and -7.5%, respectively, while the SPY returned +4.9% and -2.5%, respectively.
ARAY support price is $2.11 and resistance is $2.23 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ARAY stock will trade within this expected range on the day.